These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23813744)

  • 1. Headache-related health resource utilisation in chronic and episodic migraine across six countries.
    Sanderson JC; Devine EB; Lipton RB; Bloudek LM; Varon SF; Blumenfeld AM; Goadsby PJ; Buse DC; Sullivan SD
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1309-17. PubMed ID: 23813744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study.
    Lanteri-Minet M; Leroux E; Katsarava Z; Lipton RB; Sakai F; Matharu M; Fanning K; Manack Adams A; Sommer K; Seminerio M; Buse DC
    J Headache Pain; 2024 Aug; 25(1):134. PubMed ID: 39160483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
    Buse DC; Sakai F; Matharu M; Reed ML; Fanning K; Dabruzzo B; Lipton RB
    Headache; 2024 May; 64(5):469-481. PubMed ID: 38706199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health resource utilization of the emergency department headache "repeater".
    Maizels M
    Headache; 2002 Sep; 42(8):747-53. PubMed ID: 12390637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).
    Bloudek LM; Stokes M; Buse DC; Wilcox TK; Lipton RB; Goadsby PJ; Varon SF; Blumenfeld AM; Katsarava Z; Pascual J; Lanteri-Minet M; Cortelli P; Martelletti P
    J Headache Pain; 2012 Jul; 13(5):361-78. PubMed ID: 22644214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world healthcare resource utilization related to migraine treatment failure: a panel-based chart review in France, Germany, Italy, and Spain.
    Vo P; Gao W; Zichlin ML; Fuqua E; Fadli E; Aguirre Vazquez M; Tarancón T; Mahieu N; Maier-Peuschel M; Rossi S; Naclerio M; Ritrovato D; Swallow E
    J Med Econ; 2019 Sep; 22(9):953-959. PubMed ID: 31234672
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
    Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
    Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine-related healthcare resource use in the emergency department setting: a panel-based chart review in France, Germany, Italy, and Spain.
    Vo P; Gao W; Zichlin ML; Fuqua E; Fadli E; Aguirre Vazquez M; Tarancón T; Mahieu N; Maier-Peuschel M; Rossi S; Naclerio M; Ritrovato D; Swallow E
    J Med Econ; 2019 Sep; 22(9):960-966. PubMed ID: 31234676
    [No Abstract]   [Full Text] [Related]  

  • 11. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML
    J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional study.
    Matharu M; Katsarava Z; Buse DC; Sommer K; Reed ML; Fanning KM; Lipton RB
    Headache; 2024; 64(7):750-763. PubMed ID: 38982663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
    Adams AM; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Katsarava Z; Reed ML; Fanning K; Sommer K; Lipton RB
    Cephalalgia; 2023 Jun; 43(6):3331024231180611. PubMed ID: 37314231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of health care in Germany. A six-country comparison].
    Sawicki PT
    Med Klin (Munich); 2005 Nov; 100(11):755-68. PubMed ID: 16328186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
    Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
    Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain.
    Vo P; Swallow E; Wu E; Zichlin ML; Katcher N; Maier-Peuschel M; Naclerio M; Ritrovato D; Tiwari S; Joshi P; Ferraris M
    J Med Econ; 2021; 24(1):900-907. PubMed ID: 34311659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
    Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC
    Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database.
    Hepp Z; Rosen NL; Gillard PG; Varon SF; Mathew N; Dodick DW
    Cephalalgia; 2016 Aug; 36(9):862-74. PubMed ID: 26692400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.